Passage Bio Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Will Chou
Algemeen directeur
US$1.4m
Totale compensatie
Percentage CEO-salaris | 41.4% |
Dienstverband CEO | 2.1yrs |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | 1.3yrs |
Gemiddelde ambtstermijn bestuur | 3.6yrs |
Recente managementupdates
Recent updates
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?
Sep 24Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?
Jun 11We're Keeping An Eye On Passage Bio's (NASDAQ:PASG) Cash Burn Rate
Feb 27Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?
Nov 13We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully
Jun 23Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?
Nov 13Passage appoints William Chou CEO
Oct 10Passage Bio GAAP EPS of -$0.73 beats by $0.09
Aug 04We're A Little Worried About Passage Bio's (NASDAQ:PASG) Cash Burn Rate
Jun 03Passage Bio: Worth Keeping An Eye On
Apr 11Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?
Dec 15Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans
Aug 19Passage Bio: Price Reduced, But Without Data, Does Not Look Convincing
Jun 06Passage Bio partners with InformedDNA to offer counseling, testing for early dementia
May 03We're Hopeful That Passage Bio (NASDAQ:PASG) Will Use Its Cash Wisely
Mar 08Do Institutions Own Passage Bio, Inc. (NASDAQ:PASG) Shares?
Feb 01Passage Bio on go with PBGM01 gene therapy trial in the U.S.
Jan 04Need To Know: Passage Bio, Inc. (NASDAQ:PASG) Insiders Have Been Buying Shares
Dec 28U.K. authorizes Passage Bio's PBGM01 trial
Dec 10Passage Bio (PASG) Investor Presentation - Slideshow
Nov 16Passage Bio EPS beats by $0.13
Nov 10Passage Bio’s PBKR03 nabs Orphan drug tag and accelerated review status for Krabbe disease
Oct 28Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$77m |
Mar 31 2024 | n/a | n/a | -US$84m |
Dec 31 2023 | US$1m | US$599k | -US$102m |
Sep 30 2023 | n/a | n/a | -US$112m |
Jun 30 2023 | n/a | n/a | -US$112m |
Mar 31 2023 | n/a | n/a | -US$128m |
Dec 31 2022 | US$1m | US$112k | -US$136m |
Compensatie versus markt: De totale vergoeding ($USD 1.45M ) Will } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 653.16K ).
Compensatie versus inkomsten: De vergoeding van Will is gestegen terwijl het bedrijf verliesgevend is.
CEO
Will Chou (51 yo)
2.1yrs
Tenure
US$1,448,546
Compensatie
Dr. William Chou, MD, also known as Will, has been the Chief Executive Officer and Director of Passage Bio, Inc. from October 10, 2022 and serves as its President. Dr. Chou is an accomplished executive wit...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 2.1yrs | US$1.45m | geen gegevens | |
General Counsel & Company Secretary | 5.2yrs | US$804.69k | 0.080% $ 30.7k | |
Co-Founder & Chief Scientific Advisor | no data | geen gegevens | geen gegevens | |
Senior VP | 1.3yrs | geen gegevens | 0.046% $ 17.7k | |
Senior Vice President of Corporate Development & Investor Relations | 3.8yrs | geen gegevens | geen gegevens | |
Senior Vice President of Technical Operations | 1.3yrs | geen gegevens | geen gegevens | |
Senior Vice President of Research & Development | less than a year | geen gegevens | geen gegevens | |
Senior Vice President of Global Regulatory Affairs | less than a year | geen gegevens | geen gegevens |
1.3yrs
Gemiddelde duur
55.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van PASG wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw team.
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 2.1yrs | US$1.45m | geen gegevens | |
Director | less than a year | geen gegevens | geen gegevens | |
Independent Chairwoman of the Board | 3.8yrs | US$101.34k | 0% $ 0 | |
Independent Director | 5.7yrs | US$65.84k | 0.0081% $ 3.1k | |
Independent Director | 4.8yrs | US$69.97k | 0.031% $ 11.7k | |
Independent Director | 4.9yrs | US$73.34k | 0% $ 0 | |
Independent Director | 3.5yrs | US$69.30k | 0% $ 0 | |
Independent Director | 1.3yrs | US$49.90k | 0% $ 0 |
3.6yrs
Gemiddelde duur
53.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van PASG wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).